JPMorgan Upgrades Beam Therapeutics Inc (BEAM) to Overweight
Tweet Send to a Friend
(Updated - January 29, 2024 4:28 AM EST)
JPMorgan analyst Eric Joseph upgraded Beam Therapeutics Inc (NASDAQ: BEAM) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Eric Joseph upgraded Beam Therapeutics Inc (NASDAQ: BEAM) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
